UP!
 |
|
|
Type
|
Public |
|---|---|
| Traded as | NYSE: INVN |
| Industry | Consumer Electronics |
| Founded | 2003 |
| Headquarters | San Jose, California, US |
|
Key people
|
Behrooz Abdi, CEO |
| Products | MotionTracking Sensors |
| Parent | TDK |
| Website | invensense |
InvenSense Inc. (NYSE: INVN) is the provider of the MotionTracking sensor system on chip (SoC) which functions as a gyroscope for consumer electronic devices such as smartphones, tablets, wearables, gaming devices, optical image stabilization, and remote controls for Smart TVs. InvenSense provides the motion controller in the Nintendo Wii game controller and the Oculus Rift DK1. Its motion controllers are found in the Samsung Galaxy smartphones and most recently in the Apple iPhone 6. Founded in 2003, InvenSense is headquartered in San Jose, California with offices in Wilmington, Massachusetts, China, Taiwan, Korea, Japan, France, Canada, Slovakia and Italy.
In December 2016, the company was acquired by semiconductor company TDK for USD$1.3 billion.
InvenSense MotionTracking tracks complex user motions with the use of motion sensors such as microelectromechanical gyroscopes, (including 3-axis gyroscopes), accelerometers, compasses, and pressure sensors. the system then calibrates data, and creates a single data stream. With complex movement tracking comes a drain on battery life. In June, 2014, the company announced a low power gyroscope chip that used just under six milliwatts of power in a chip and was just 0.75 millimeters thick.
InvenSense also provides Optical Image Stabilisation for Smartphone cameras, which are important to detect hand movements and reduce shake in photographs. InvenSense's compact gyroscope was designed to provide antishake features on the smallest camera phones.
| 2016-07-06 | Reiterated Rating | KeyCorp | Hold | |
| 2016-05-25 | Reiterated Rating | Roth Capital | Buy | $10.00 |
| 2016-05-11 | Downgrade | Canaccord Genuity | Buy to Hold | $10.00 to $6.22 |
| 2016-05-10 | Lower Price Target | Topeka Capital Markets | Buy | $9.00 to $8.00 |
| 2016-05-10 | Reiterated Rating | Roth Capital | Buy | |
| 2016-05-10 | Reiterated Rating | Drexel Hamilton | Hold | |
| 2016-05-10 | Reiterated Rating | Oppenheimer | Hold | |
| 2016-05-10 | Reiterated Rating | Morgan Stanley | Hold | |
| 2016-05-10 | Reiterated Rating | Oppenheimer Holdings Inc. | Hold | |
| 2016-04-14 | Reiterated Rating | Pacific Crest | Hold | $7.00 |
| 2016-04-12 | Reiterated Rating | Rosenblatt Securities | Neutral | $10.00 to $7.20 |
| 2016-03-01 | Initiated Coverage | Drexel Hamilton | Hold | |
| 2016-01-28 | Reiterated Rating | Canaccord Genuity | Buy | $14.00 to $10.00 |
| 2016-01-28 | Lower Price Target | Topeka Capital Markets | Buy | $14.00 to $9.00 |
| 2016-01-28 | Downgrade | Barrington Research | Outperform to Market Perform | |
| 2016-01-13 | Initiated Coverage | Benchmark Co. | Hold | $9.00 |
| 2016-01-12 | Reiterated Rating | Roth Capital | Buy | |
| 2016-01-08 | Downgrade | Rosenblatt Securities | Buy to Neutral | $10.00 |
| 2015-12-11 | Reiterated Rating | Roth Capital | Buy | $19.00 |
| 2015-10-29 | Lower Price Target | Craig Hallum | Hold | $13.00 |
| 2015-10-29 | Upgrade | Barrington Research | Market Perform to Outperform | |
| 2015-10-29 | Reiterated Rating | Canaccord Genuity | Buy | $15.00 to $14.00 |
| 2015-10-29 | Lower Price Target | Northland Securities | Market Perform | $15.00 to $12.50 |
| 2015-10-29 | Lower Price Target | Topeka Capital Markets | Buy | $18.00 to $14.00 |
| 2015-10-23 | Reiterated Rating | Roth Capital | Buy | $19.00 |
| 2015-10-13 | Reiterated Rating | Rosenblatt Securities | Buy | $15.00 |
| 2015-08-13 | Reiterated Rating | Canaccord Genuity | Buy | |
| 2015-08-05 | Downgrade | Barrington Research | Outperform to Market Perform | |
| 2015-08-05 | Lower Price Target | Canaccord Genuity | Buy | $19.00 to $15.00 |
| 2015-08-05 | Lower Price Target | Ascendiant Capital Markets | Buy | $20.00 to $17.00 |
| 2015-08-05 | Downgrade | Northland Securities | Outperform to Market Perform | $18.00 to $15.00 |
| 2015-08-04 | Reiterated Rating | Roth Capital | Buy | $20.00 |
| 2015-06-09 | Reiterated Rating | Oppenheimer | Hold | |
| 2015-06-08 | Upgrade | Northland Securities | Market Perform to Outperform | $17.50 to $18.00 |
| 2015-05-11 | Reiterated Rating | Pacific Crest | Equal Weight | |
| 2015-05-11 | Reiterated Rating | Roth Capital | Buy | $22.00 to $20.00 |
| 2015-05-05 | Set Price Target | Ascendiant Capital Markets | Buy | $20.00 |
| 2015-05-05 | Downgrade | Craig Hallum | Buy to Hold | $15.00 |
| 2015-05-05 | Boost Price Target | Canaccord Genuity | Buy | $18.00 to $19.00 |
| 2015-04-14 | Upgrade | Rosenblatt Securities | Neutral to Buy | |
| 2015-03-19 | Initiated Coverage | Rosenblatt Securities | Neutral | $15.00 |
| 2015-02-23 | Initiated Coverage | Barrington Research | Outperform | $20.00 |
| 2015-01-30 | Lower Price Target | Imperial Capital | Outperform | $23.00 to $20.00 |
| 2015-01-27 | Set Price Target | Roth Capital | Buy | $25.00 to $22.00 |
| 2014-11-13 | Initiated Coverage | JMP Securities | Outperform | $18.00 |
| 2014-10-29 | Lower Price Target | Imperial Capital | Outperform | $28.00 to $23.00 |
| 2014-10-29 | Downgrade | Northland Capital | Outperform to Market Perform | $30 to $17.50 |
| 2014-10-29 | Reiterated Rating | Canaccord Genuity | Buy | $29.00 to $21.00 |
| 2014-10-29 | Reiterated Rating | Goldman Sachs | Neutral | |
| 2014-10-29 | Downgrade | Northland Securities | Outperform to Market Perform | $30.00 to $17.50 |
| 2014-10-29 | Downgrade | Piper Jaffray | Overweight to Neutral | $29.00 to $17.00 |
| 2014-10-29 | Downgrade | Pacific Crest | Outperform to Sector Perform | $28.00 |
| 2014-10-29 | Reiterated Rating | Goldman Sachs Group Inc. | Neutral | |
| 2014-10-29 | Downgrade | Piper Jaffray Cos. | Overweight to Neutral | $29.00 to $17.00 |
| 2014-10-01 | Upgrade | Needham | Buy to Strong Buy | |
| 2014-10-01 | Upgrade | Needham & Company LLC | Buy to Strong-Buy | $28.00 |
| 2014-09-22 | Downgrade | Robert W. Baird | Outperform to Neutral | $30.00 to $23.00 |
| 2014-08-18 | Downgrade | Goldman Sachs | Buy to Neutral | $25.00 |
| 2014-08-08 | Initiated Coverage | Canaccord Genuity | Buy | $29.00 |
| 2014-07-31 | Boost Price Target | Needham & Company LLC | $22.00 to $28.00 | |
| 2014-07-31 | Boost Price Target | Evercore ISI | $25.00 to $32.00 | |
| 2014-07-31 | Boost Price Target | Robert W. Baird | $28.00 to $30.00 | |
| 2014-07-30 | Upgrade | Ascendiant Capital Markets | Neutral to Buy | $29.00 |
| 2014-07-30 | Boost Price Target | Imperial Capital | Outperform | $24.00 to $28.00 |
| 2014-07-30 | Reiterated Rating | Topeka Capital Markets | Buy | $22.00 to $27.00 |
| 2014-07-30 | Upgrade | Morgan Stanley | Buy | $29.00 |
| 2014-07-30 | Boost Price Target | Northland Securities | Outperform | $24.00 to $30.00 |
| 2014-07-30 | Boost Price Target | Pacific Crest | Outperform | $26.00 to $28.00 |
| 2014-07-28 | Boost Price Target | Roth Capital | Buy | $26.00 to $28.00 |
| 2014-07-14 | Boost Price Target | Robert W. Baird | $22.00 to $28.00 | |
| 2014-06-27 | Set Price Target | Piper Jaffray | $22.00 to $25.00 | |
| 2014-06-23 | Boost Price Target | Pacific Crest | Outperform | $22.00 to $26.00 |
| 2014-05-14 | Initiated | Imperial Capital | Outperform | $21 |
| 2014-05-13 | Initiated Coverage | Imperial Capital | Outperform | $21.00 |
| 2014-05-02 | Lower Price Target | Topeka Capital Markets | $25.00 to $22.00 | |
| 2014-05-02 | Lower Price Target | Pacific Crest | $27.00 to $22.00 | |
| 2014-05-02 | Upgrade | Needham & Company LLC | Hold to Buy | $22.00 |
| 2014-05-02 | Lower Price Target | Evercore ISI | $28.00 to $25.00 | |
| 2014-04-07 | Boost Price Target | Pacific Crest | Outperform | $20.00 to $27.00 |
| 2014-04-01 | Downgrade | Oppenheimer | Outperform to Market Perform | $20.00 |
| 2014-03-28 | Upgrade | Roth Capital | Neutral to Buy | $18.00 to $26.00 |
| 2014-03-21 | Boost Price Target | Evercore ISI | $24.00 to $28.00 | |
| 2014-03-17 | Boost Price Target | Robert W. Baird | $23.00 to $28.00 | |
| 2014-03-12 | Initiated Coverage | Piper Jaffray | Overweight | |
| 2014-03-11 | Initiated Coverage | Ascendiant Capital Markets | Hold | |
| 2014-03-04 | Boost Price Target | Topeka Capital Markets | $21.00 to $25.00 | |
| 2014-02-26 | Boost Price Target | Evercore ISI | $22.00 to $24.00 | |
| 2014-02-11 | Boost Price Target | Robert W. Baird | $20.00 to $23.00 | |
| 2014-01-30 | Reiterated Rating | Goldman Sachs | Buy | |
| 2014-01-30 | Boost Price Target | Oppenheimer | $1.00 to $20.00 | |
| 2014-01-30 | Boost Price Target | Pacific Crest | $19.00 to $20.00 | |
| 2014-01-02 | Boost Price Target | Maxim Group | Buy | $20.00 to $24.00 |
| 2013-11-11 | Reiterated Rating | Piper Jaffray | Overweight | $25.00 |
| 2013-10-30 | Boost Price Target | Topeka Capital Markets | Buy | $20.00 to $22.00 |
| 2013-10-30 | Lower Price Target | Oppenheimer | Outperform | $24.00 to $21.00 |
| 2013-10-30 | Lower Price Target | Evercore ISI | Overweight | $21.00 to $20.00 |
| 2013-10-30 | Downgrade | Roth Capital | Buy to Neutral | |
| 2013-10-28 | Reiterated Rating | Maxim Group | Buy | $23.00 |
| 2013-10-15 | Reiterated Rating | Needham & Company LLC | Buy | $20.00 |
| 2013-10-15 | Boost Price Target | Oppenheimer | Outperform | $19.00 to $24.00 |
| 2013-10-15 | Boost Price Target | Maxim Group | Buy | $18.00 to $23.00 |
| 2013-09-23 | Reiterated Rating | Needham & Company LLC | Buy | $20.00 |
| 2013-09-12 | Reiterated | Maxim Group | Buy | $20 to $21 |
| 2013-09-04 | Upgrade | Robert W. Baird | Neutral to Outperform | $16 to $23 |
| 2013-08-27 | Reiterated | Maxim Group | Buy | $18 to $20 |
| 2013-08-22 | Initiated | Needham | Buy | $20 |
| 2013-06-04 | Reiterated | Maxim Group | Buy | $12 to $15 |
| 2013-05-29 | Initiated | Northland Capital | Outperform | $17.50 |
| 2013-02-27 | Downgrade | Robert W. Baird | Outperform to Neutral | $16 to $13 |
| 2013-01-10 | Reiterated | Maxim Group | Buy | $14 to $15 |
| 2012-11-13 | Initiated | Maxim Group | Buy | $14 |
| 2016-07-06 | Reiterated Rating | KeyCorp | Hold | |
| 2016-05-25 | Reiterated Rating | Roth Capital | Buy | $10.00 |
| 2016-05-11 | Downgrade | Canaccord Genuity | Buy to Hold | $10.00 to $6.22 |
| 2016-05-10 | Lower Price Target | Topeka Capital Markets | Buy | $9.00 to $8.00 |
| 2016-05-10 | Reiterated Rating | Roth Capital | Buy |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In INVN 13 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| BlackRock Fund Advisors | 2.51M |
| BlackRock Institutional Trust Company, N.A. | 2.18M |
| BLACKROCK ADVISORS LLC | 0.45M |
| BlackRock Investment Management, LLC | 0.34M |
| GRUBER & MCBAINE CAPITAL MANAGEMENT LLC | 0.12M |
| MCGLINN CAPITAL MANAGEMENT INC | 65800 |
| BAIRD ROBERT W & CO INC /WI/ | 52495 |
| BlackRock Group LTD | 37087 |
| MetLife Securities, Inc | 2575 |
| MANAGED ACCOUNT ADVISORS LLC | 1500 |
| HABERER REGISTERED INVESTMENT ADVISOR INC | 1000 |
| ALPHAGEN SECURITIES LLC | 520 |
| NEW ENGLAND SECURITIES CORP /MA/ | 405 |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| Nasiri Steven Saeed | 5.69% (5060790) | INVN / |
| Artiman, L.L.C. | 0.16% (140528) | INVN / |
| ARTIMAN VENTURES L P | 0.14% (120429) | INVN / |
| TACHNER ADAM H VP & General Counsel | 0.08% (72221) | INVN / |
| Lloyd Stephen Vice President | 0.05% (46904) | INVN / |
| KROCK ALAN Chief Financial Officer | 0.01% (5424) | INVN / |
UM